Vanguard Group Inc Biolife Solutions Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Biolife Solutions Inc stock. As of the latest transaction made, Vanguard Group Inc holds 2,868,335 shares of BLFS stock, worth $61.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,868,335
Previous 2,571,608
11.54%
Holding current value
$61.3 Million
Previous $41.8 Million
27.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding BLFS
# of Institutions
156Shares Held
44.1MCall Options Held
207KPut Options Held
18.3K-
Casdin Capital, LLC New York, NY8.71MShares$186 Million13.04% of portfolio
-
Black Rock Inc. New York, NY5.46MShares$117 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.81MShares$38.7 Million0.02% of portfolio
-
William Blair Investment Management, LLC Chicago, IL1.73MShares$36.9 Million0.09% of portfolio
-
Fred Alger Management, LLC New York, NY1.49MShares$31.8 Million0.14% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $912M
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...